(Updated - February 13, 2025 6:20 AM EST)

Leerink Partners analyst Jonathan Chang upgraded Genmab A/S (NASDAQ: GMAB) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE